CDT Equity Inc. (CDT) Sells Subsidiary Conduit Pharmaceuticals for $7 Million
CDT Equity Inc. (CDT) sold its subsidiary Conduit Pharmaceuticals Limited to Corvus Capital Limited for $7 million, according to an SEC 8-K filing.
M&A
Merus N.V. (MRUS) Acquired by Genmab in $6.9 Billion Deal, Announces Leadership Changes
Merus N.V. (MRUS) completed its acquisition by Genmab A/S for $6.9 billion, resulting in a change of control and new executive appointments.
Merus N.V. (MRUS) Acquired by Genmab for $6.9 Billion, Completes Change in Control
Merus N.V. (MRUS) completed its acquisition by Genmab A/S for approximately $6.9 billion, resulting in a change in control and leadership changes.
Climb Bio (CLYM) Exchanges 20.4 Million Shares for Pre-Funded Warrants with RA Capital
Climb Bio, Inc. (CLYM) exchanged 20.4 million shares of common stock for pre-funded warrants in a deal with RA Capital Management.
Climb Bio (CLYM) Exchanges 20.4 Million Shares for Pre-Funded Warrants with RA Capital
Climb Bio (CLYM) exchanged 20.4 million shares for pre-funded warrants with RA Capital Management, per an SEC 8-K filing.